Search for a command to run...
President & CEO, Buck Institute for Research on Aging · Professor, UCSF
Verdin's research focuses on NAD+ metabolism, sirtuins, and the role of the microbiome in aging. He argues that NAD+ decline is a central driver of the aging process and that restoring it through precursors like NMN or NR can meaningfully extend healthspan.
| Molecule | Dose | Timing | Tier | Hallmarks | Cart |
|---|---|---|---|---|---|
NMN or NR Verdin uses NR; both are valid NAD+ precursors | 500 mg | Morning | II | Nutrient-sensing dysreg.Stem cell exhaustion | |
Omega-3 | 1–2 g | With meal | I | Microbiome alterationsDisabled autophagy | |
Vitamin D3 | 2000–4000 IU | Morning with fat | I | Disabled autophagy | |
Magnesium | 300 mg | Evening | II | Telomere attritionDisabled autophagy |
Tier I = multiple RCTs in humans · Tier II = human trials, early stage · Tier III = mechanism / animal studies only
Verdin is one of the most rigorous scientists in the NAD+ field and is careful to distinguish what animal data shows vs. what is proven in humans. His supplement stack is conservative relative to Sinclair's, reflecting his higher evidence threshold.
See how Eric's stack compares to Attia, Sinclair, Patrick, Huberman, and Johnson side-by-side.
Open comparison tool →